Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Americas Interventional Radiology Market

ID: MRFR/MED/0409-HCR
117 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Americas Interventional Radiology Market Research Report Information: by Type (MRI, Ultrasound imaging, CT scan, angiography), by Procedure (diagnostic, therapeutic), by Application (cardiology, oncology, urology & nephrology), by End User (hospitals, catheterization labs, and ambulatory surgical centers) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Americas Interventional Radiology Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Billion)
  49.     4.1.1 Oncology
  50.     4.1.2 Urology
  51.     4.1.3 Gastroenterology
  52.     4.1.4 Cardiology
  53.     4.1.5 Pulmonology
  54.   4.2 Healthcare, BY Product Type (USD Billion)
  55.     4.2.1 Catheters
  56.     4.2.2 Guidewires
  57.     4.2.3 Embolization Devices
  58.     4.2.4 Ablation Devices
  59.     4.2.5 Stents
  60.   4.3 Healthcare, BY End User (USD Billion)
  61.     4.3.1 Hospitals
  62.     4.3.2 Ambulatory Surgical Centers
  63.     4.3.3 Diagnostic Imaging Centers
  64.     4.3.4 Specialty Clinics
  65.   4.4 Healthcare, BY Procedure Type (USD Billion)
  66.     4.4.1 Biopsy
  67.     4.4.2 Drainage
  68.     4.4.3 Ablation
  69.     4.4.4 Embolization
  70.     4.4.5 Vascular Intervention
  71.   4.5 Healthcare, BY Technology (USD Billion)
  72.     4.5.1 Fluoroscopy
  73.     4.5.2 Ultrasound
  74.     4.5.3 CT Imaging
  75.     4.5.4 MRI Imaging
  76.     4.5.5 Radiofrequency Ablation
  77. 5 SECTION V: COMPETITIVE ANALYSIS
  78.   5.1 Competitive Landscape
  79.     5.1.1 Overview
  80.     5.1.2 Competitive Analysis
  81.     5.1.3 Market share Analysis
  82.     5.1.4 Major Growth Strategy in the Healthcare
  83.     5.1.5 Competitive Benchmarking
  84.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  85.     5.1.7 Key developments and growth strategies
  86.       5.1.7.1 New Product Launch/Service Deployment
  87.       5.1.7.2 Merger & Acquisitions
  88.       5.1.7.3 Joint Ventures
  89.     5.1.8 Major Players Financial Matrix
  90.       5.1.8.1 Sales and Operating Income
  91.       5.1.8.2 Major Players R&D Expenditure. 2023
  92.   5.2 Company Profiles
  93.     5.2.1 Medtronic (US)
  94.       5.2.1.1 Financial Overview
  95.       5.2.1.2 Products Offered
  96.       5.2.1.3 Key Developments
  97.       5.2.1.4 SWOT Analysis
  98.       5.2.1.5 Key Strategies
  99.     5.2.2 Boston Scientific (US)
  100.       5.2.2.1 Financial Overview
  101.       5.2.2.2 Products Offered
  102.       5.2.2.3 Key Developments
  103.       5.2.2.4 SWOT Analysis
  104.       5.2.2.5 Key Strategies
  105.     5.2.3 Johnson & Johnson (US)
  106.       5.2.3.1 Financial Overview
  107.       5.2.3.2 Products Offered
  108.       5.2.3.3 Key Developments
  109.       5.2.3.4 SWOT Analysis
  110.       5.2.3.5 Key Strategies
  111.     5.2.4 Siemens Healthineers (DE)
  112.       5.2.4.1 Financial Overview
  113.       5.2.4.2 Products Offered
  114.       5.2.4.3 Key Developments
  115.       5.2.4.4 SWOT Analysis
  116.       5.2.4.5 Key Strategies
  117.     5.2.5 Bayer (DE)
  118.       5.2.5.1 Financial Overview
  119.       5.2.5.2 Products Offered
  120.       5.2.5.3 Key Developments
  121.       5.2.5.4 SWOT Analysis
  122.       5.2.5.5 Key Strategies
  123.     5.2.6 Cook Medical (US)
  124.       5.2.6.1 Financial Overview
  125.       5.2.6.2 Products Offered
  126.       5.2.6.3 Key Developments
  127.       5.2.6.4 SWOT Analysis
  128.       5.2.6.5 Key Strategies
  129.     5.2.7 Terumo Corporation (JP)
  130.       5.2.7.1 Financial Overview
  131.       5.2.7.2 Products Offered
  132.       5.2.7.3 Key Developments
  133.       5.2.7.4 SWOT Analysis
  134.       5.2.7.5 Key Strategies
  135.     5.2.8 Philips (NL)
  136.       5.2.8.1 Financial Overview
  137.       5.2.8.2 Products Offered
  138.       5.2.8.3 Key Developments
  139.       5.2.8.4 SWOT Analysis
  140.       5.2.8.5 Key Strategies
  141.     5.2.9 Stryker Corporation (US)
  142.       5.2.9.1 Financial Overview
  143.       5.2.9.2 Products Offered
  144.       5.2.9.3 Key Developments
  145.       5.2.9.4 SWOT Analysis
  146.       5.2.9.5 Key Strategies
  147.   5.3 Appendix
  148.     5.3.1 References
  149.     5.3.2 Related Reports
  150. 6 LIST OF FIGURES
  151.   6.1 MARKET SYNOPSIS
  152.   6.2 NORTH AMERICA MARKET ANALYSIS BY APPLICATION
  153.   6.3 NORTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
  154.   6.4 NORTH AMERICA MARKET ANALYSIS BY END USER
  155.   6.5 NORTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE
  156.   6.6 NORTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
  157.   6.7 KEY BUYING CRITERIA OF HEALTHCARE
  158.   6.8 RESEARCH PROCESS OF MRFR
  159.   6.9 DRO ANALYSIS OF HEALTHCARE
  160.   6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  161.   6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  162.   6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
  163.   6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  164.   6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  165.   6.15 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
  166.   6.16 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
  167.   6.17 HEALTHCARE, BY END USER, 2024 (% SHARE)
  168.   6.18 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
  169.   6.19 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
  170.   6.20 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
  171.   6.21 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
  172.   6.22 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
  173.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  174. 7 LIST OF TABLES
  175.   7.1 LIST OF ASSUMPTIONS
  176.     7.1.1
  177.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  178.     7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  179.     7.2.2 BY PRODUCT TYPE, 2026-2035 (USD Billion)
  180.     7.2.3 BY END USER, 2026-2035 (USD Billion)
  181.     7.2.4 BY PROCEDURE TYPE, 2026-2035 (USD Billion)
  182.     7.2.5 BY TECHNOLOGY, 2026-2035 (USD Billion)
  183.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  184.     7.3.1
  185.   7.4 ACQUISITION/PARTNERSHIP
  186.     7.4.1

North America Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2026-2035)

  • Oncology
  • Urology
  • Gastroenterology
  • Cardiology
  • Pulmonology

Healthcare By Product Type (USD Billion, 2026-2035)

  • Catheters
  • Guidewires
  • Embolization Devices
  • Ablation Devices
  • Stents

Healthcare By End User (USD Billion, 2026-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers
  • Specialty Clinics

Healthcare By Procedure Type (USD Billion, 2026-2035)

  • Biopsy
  • Drainage
  • Ablation
  • Embolization
  • Vascular Intervention

Healthcare By Technology (USD Billion, 2026-2035)

  • Fluoroscopy
  • Ultrasound
  • CT Imaging
  • MRI Imaging
  • Radiofrequency Ablation

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓